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Abstract: We utilized HL-60 cells as a model
system to examine the regulation of ctsb gene
expression by differentiating agents. Inducers of
monocytic differentiation [phorbol ester (PMA),
calcitriol (D3), and sodium butyrate (NaB)] and
inducers of granulocytic differentiation [all-trans
retinoic acid (RA) and 9-cis retinoic acid (9-cis
RA)] increase ctsb mRNA levels in a dose-depen-
dent manner as determined by Northern blot hybrid-
ization. D3 and retinoids exert additive effects,
suggesting that these agents act in part through
distinct pathways. Actinomycin D decay experi-
ments indicate that D3, NaB, RA, and 9-cis RA do
not alter mRNA stability. In contrast, PMA mark-
edly increases the half-life of ctsb mRNA. In tran-
sient transfection assays, PMA and NaB both stimu-
late transcription of the luciferase reporter gene
placed under the control of ctsb promoter frag-
ments. Thus, inducers of HL-60 cell differentiation
can regulate the expression of the ctsb gene at both
transcriptional and posttranscriptional levels. J.
Leukoc. Biol. 66: 609–616; 1999.
Key Words: mRNA · transcriptional regulation · posttranscrip-
tional regulation · monocyte · granulocyte
INTRODUCTION
Cathepsin B (ctsb) is a lysosomal cysteine protease with a broad
substrate specificity [1]. Ctsb is expressed in most tissues, but
its levels vary widely among different tissues or cell types [2–6].
Macrophages and osteoclasts produce high levels of ctsb
[7–12], as do malignant tumor cells of various origins [for a
review, see ref. 13]. Several groups have reported increases in
ctsb transcripts or ctsb activity in association with differentia-
tion of specific cell types in vivo or in vitro. For instance, both
ctsb activity and ctsb mRNA levels increase during rodent and
calf myoblast-myotube differentiation [14–16]. Ctsb expression
is also enhanced during the early stages of osteogenic differen-
tiation in mouse mandibular condyles in vitro [17]. Maturation
of human monocytes into macrophages in vitro is accompanied
by an increase in ctsb activity [7]. Differentiation of the human
U937 promonocytic cell line, induced by phorbol myristate
acetate (PMA) or granulocyte-monocyte colony-stimulating
factor, triggers an increase in ctsb mRNA and protein [18]. PMA
increases ctsb mRNA levels and stimulates secretion of proca-
thepsin B from colon carcinoma cells [19, and D. Keppler,
personal communication]. Induction of monocytic differentia-
tion of HL-60 cells by PMA increases ctsb protein and activity
[20, 21]. Because HL-60 cells can be committed toward
granulocytic or monocytic pathways with a variety of agents
[22], we utilized these cells as a model system to investigate
whether differentiating agents directly regulate the expression
of the ctsb gene. We investigated the effects of PMA, calcitriol
(D3), sodium butyrate (NaB), all-trans retinoic acid (RA), and
9-cis retinoic acid (9-cis RA) on ctsb mRNA levels and
transcriptional activity of the ctsb promoter in HL-60 cells.
MATERIALS AND METHODS
Reagents
The PMA and all-trans RA (Sigma Chemical Co., St. Louis, MO) were dissolved
in dimethyl sulfoxide. The sodium butyrate, lithium chloride, actinomycin D,
and cycloheximide (Sigma) were dissolved in water. The 9-cis RA (Sigma) and
calcitriol (a kind gift of Dr. Milan R. Uskokovic, Hoffman La-Roche, Nutley, NJ)
were dissolved in ethanol. The nitroblue tetrazolium (Sigma) was dissolved in
phosphate-buffered saline containing 1 mM CaCl2, 1 mM MgCl2, and 5 mM
glucose.
Cells
The HL-60 cells (American Type Culture Collection, Rockville, MD) were
maintained in RPMI-1640 supplemented with 10% heat-inactivated fetal calf
serum, 5 mM L-glutamine, 50 units/mL penicillin, and 50 µg/mL streptomycin
at 37°C and 5% CO2. The medium was replaced every 2–3 days.
Northern blots
Cells were seeded at 2 to 8 3 105/mL in 100-mm plates and treated as
indicated in Results. Total cellular RNA was isolated using a modified
guanidinium thiocyanate procedure [23]. Total RNA (10–20 µg) was denatured,
fractionated on a 1% formaldehyde-agarose gel, and transferred onto a
NYTRAN1 membrane (Schleicher & Schuell). The blots were then hybridized
overnight at 42°C with radiolabeled probes generated from randomly primed
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cDNAs for human ctsb (0.8 kb EcoRI fragment of pLC343 [24]) or chicken
gapdh (1.2 kb PstI fragment of pGAD-28 [25]). Northern blots were washed for
10 min at 45°C in 23 SSPE buffer [26]/0.2% sodium dodecyl sulfate, for 1 h at
60°C in 0.23 SSPE buffer/2% sodium dodecyl sulfate. The blots were initially
exposed to Kodak X-OMAT film with intensifying screens at 270°C to produce
autoradiographs. The blots were subsequently exposed to a phosphor screen
and bands were quantitated with a PhosphoImager (Molecular Dynamics,
Sunnyvale, CA). Results of ctsb expression were normalized based on gapdh
expression. All treatment conditions were examined a minimum of three times.
Cellular differentiation analysis
Ten thousand cells were plated into 2 mL of media in 24-well plates and treated
with RA (10-7 M), D3 (10-7 M), 9-cis RA (10-7 M), PMA (10-8 M), or NaB (5 3
10-4 M) for 24 h. The cells were then harvested and incubated in 0.2% nitroblue
tetrazolium/0.15 µM PMA for 20 min at 37°C. Aliquots were counted for total
number of cells and those containing formazan granules. All experiments were
performed a minimum of four times.
Genomic ctsb clones and sequencing of the
promoter region
pCBG1 genomic cosmid clone was a gift from Dr. Dunne Fong [27]. This clone
contains the ctsb gene with approximately 6 kb of 58 flanking sequences
upstream of exon 1 [13]. A 2.2-kb SacI fragment from pCBG1, including 1.8 kb
of 58-flanking region, exon 1 (135 bp), and 0.3 kb of intron 1, was subcloned
into pBluescript KS(1) (Stratagene) to generate pICB8. Two extensive,
overlapping sets of nested deletion variants of this plasmid were constructed
from either end of the insert in order to sequence both strands of the ctsb
promoter region. The sequence has been submitted to Genbank (accession no.
AF086639). pSCB1 was constructed by subcloning the 2.2-kb ctsb insert into
promoterless pGL3-Basic vector (Promega) upstream of the beetle luciferase
reporter gene (see Fig. 6). pSCB2 is similar to pSCB1, but does not contain the
last 79 bp of exon 1 and intron 1 sequences (it was generated by removing ctsb
sequences downstream of the first PstI site in exon 1). pSCB2 contains 1774 bp
of 58-flanking region and the first 56 bp of exon 1. pSCB8 is a nested deletion
variant containing the last 105 bp of the insert in pSCB2, which includes 49 bp
of 58-flanking region and 56 bp of exon 1.
Transfections
After optimizing conditions to achieve pulse times of 34–38 ms (260–270 volts,
960 µF), we transiently transfected plasmids into HL-60 cells (6 3 106 cells in
300 µL) via electroporation [28] using a Gene Pulser (Bio-Rad). Cells from a
single transfection were equally divided into two dishes, and agents known to
stimulate ctsb mRNA levels were added to one of the dishes. All cells were
harvested after 12–16 h, and equal amounts of protein from each sample were
used to measure luciferase activity (with a kit from Promega). Results were
normalized by comparing only paired dishes (treated versus untreated) from a
single transfection [29–32]. NaB treatment can enhance transfection efficiency
in fibroblasts [33, 34]. To rule out potential confounding effects in the HL-60
cells, we co-transfected a plasmid containing the SV40 promoter upstream of
the renilla luciferase gene with the pSCB1, pSCB2, and pSCB8 plasmids before
NaB treatment. For these transfections, both the beetle and renilla luciferase
activities were assessed via a single tube dual luciferase assay (kit from
Promega). Relative stimulation of expression of the CTSB promoter-beetle
luciferase by NaB was normalized to the renilla activity.
RESULTS
We examined steady-state levels of ctsb mRNA in HL-60 cells
upon treatment with various differentiating agents. The mono-
cytic inducers PMA, D3, and NaB and the granulocytic
inducers RA and 9-cis RA increased ctsb mRNA levels in
HL-60 cells (Fig. 1, Table 1). PMA exerted the most
pronounced effect, increasing ctsb mRNA levels more than
20-fold relative to gapdh after 24 h. However, PMA also
reduced gapdh mRNA levels, so that the absolute increase in
ctsb mRNA was 7.5-fold. Prolonged treatment with PMA
increased the ctsb levels further, while having no additional
effect on gapdh mRNA levels. The other agents increased ctsb
mRNA levels approximately two- to fourfold from 24 to 72 h,
with no significant effect on gapdh mRNA levels. HL-60 cells
expressed both the 2.2- and 4.0-kb forms of ctsb mRNA.
Throughout the experiments, treatments did not significantly
alter the ratio of the 2.2- and 4.0-kb mRNA forms.
Because all of the agents exerted an effect by 24 h of
treatment, we performed a shorter-term kinetic assay. Ctsb
mRNA levels increased as early as 3 h after PMA, RA, 9-cis
RA, or NaB treatment and rose progressively throughout the
duration of the assay (Fig. 2). D3 had a more delayed action,
with ctsb mRNA increasing by 12 h of treatment. The lack of a
response within 1 h of treatment suggested that the agents
tested may affect ctsb gene expression indirectly. Indeed,
protein synthesis is required for the full extent of stimulation of
ctsb expression by PMA. Co-treatment with PMA and the
protein synthesis inhibitor cycloheximide (10 µg/mL) reduced
the level of ctsb mRNA at 24 h as compared to PMA treatment
alone (data not shown). However, cycloheximide by itself
increased the level of ctsb mRNA approximately fourfold (data
not shown; see Discussion). The other inducing agents, when
used in combination with cycloheximide, neither increased nor
reduced ctsb mRNA levels compared with cycloheximide alone.
Fig. 1. Cathepsin B expression in HL-60 cells. Cells were treated for 24 h with
10-8 M PMA, 10-7 M D3, 10-7 M RA, 10-7 M 9-cis RA, or 5 3 1024 M NaB. Total
cellular RNA (10 µg/lane) was hybridized with a ctsb cDNA probe as described
in Materials and Methods. Blots were stripped and rehybridized with a gapdh
cDNA probe as a loading control. The relative stimulation of ctsb mRNA levels
was quantified for each agent (see Table 1).
TABLE 1. Relative Stimulation of ctsb mRNA Levels
at 24, 48, and 72 ha
Treatment 24 h 48 h 72 h
PMA 21.6 6 10.1 (7) 17.8 6 2.3 (3) 39.9 6 4.6 (3)
D3 1.6 6 0.4 (12) 1.8 6 0.3 (8) 3.4 6 0.3 (4)
RA 2.5 6 0.9 (12) 1.7 6 0.3 (8) 3.2 6 1.1 (4)
9-cis RA 2.8 6 0.4 (13) 2.1 6 0.3 (8) 2.5 6 0.5 (4)
NaB 4.1 6 1.3 (7) 1.4 6 0.0 (3) n.d.b
a Mean increase 6 standard deviation. Number of repeats is indicated in
parentheses. Levels of ctsb mRNA in each experiment were calculated relative
to control (vehicle-treated) sample in each blot. Fold stimulation is normalized
for gapdh levels.—bNot determined.
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We verified that the differentiating agents that increase ctsb
mRNA levels act in a dose-dependent manner at the 24-h time
point (Fig. 3). The optimal dose of PMA for induction of ctsb
mRNA was 10 nM. At this concentration, more than 90% of
cells were adherent, a characteristic of HL-60 cells undergoing
differentiation toward the macrophage phenotype [22]. The
monocyte inducers D3 and NaB and the granulocytic inducers
RA and 9-cis RA increased the cytoplasm/nucleus ratio of
HL-60 cells but did not induce an adherent phenotype at the
times and concentrations tested, as reported previously [22]. D3
and 9-cis RA stimulated gapdh-normalized ctsb mRNA levels
maximally at 10-7 M, whereas RA increased ctsb mRNA levels
further at 10-6 M (Fig. 3). Maximal stimulation of ctsb expres-
sion by NaB was seen with a 10-3 M concentration. We observed
morphological alterations suggestive of apoptosis (vacuolization
and cell fragmentation) after 24-h treatment with 10-6 M D3,
RA, and 9-cis RA, and with NaB concentrations above 5 3
10-4 M.
To assess the extent of cell differentiation upon treatment
with the above agents, we performed nitroblue tetrazolium
assays. The ability to reduce nitroblue tetrazolium is a biochemi-
cal marker of maturation of HL-60 cells. Treatment of these cells
with the monocytic inducers D3 and NaB and the granulocytic
inducers RA and 9-cis RA for 24 h resulted in differentiation of
fewer than 1% of cells (Table 2) as assessed by this assay. This
suggests that these agents do not induce full differentiation of
HL-60 cells within 24 h at the concentrations tested. However,
prolonged treatment for 5 days resulted in differentiation of
63–83% of cells. Thus, the regulation of ctsb gene expression by
these factors is not secondary to terminal differentiation, but
likely occurs before the activation of signals necessary for
differentiation. Despite the lack of formazan granule staining of
the PMA-treated cells (Table 2), both the 24- and 120-h
treatments resulted in morphological changes, notably com-
plete adherence and spreading of the cells. Therefore, PMA
already induces some degree of differentiation of HL-60 cells
toward the monocyte/macrophage pathway as early as 24 h.
We performed actinomycin D decay assays (Fig. 4A) to
determine whether differentiation-inducing agents act by alter-
ing ctsb mRNA stability as opposed to increasing the level of
transcription from the gene. In the absence of prior treatment,
ctsb mRNA levels rapidly decreased upon addition of 5 µg/mL
actinomycin D (with a half-life of ,3 h). D3, RA, 9-cis RA, and
NaB exerted no significant effect on the decay of ctsb mRNA. In
contrast, PMA increased ctsb mRNA stability under these
conditions, with approximately 80% of transcripts remaining
after 8 h (Fig. 4B), resulting in an approximate half-life of 24 h.
Because actinomycin D can induce apoptosis in HL-60 cells
[35], we repeated the assay with lower doses of this agent. We
Fig. 2. Kinetics of ctsb mRNA expression in response to PMA, D3, RA, 9-cis
RA, or NaB. HL-60 cells were treated with 10-8 M PMA, 10-7 M D3, 10-7 M RA,
10-7 M 9-cis RA, or 5 3 10-4 M NaB, for 1–12 h as indicated. Northern blotting
was performed as described in Figure 1.
Fig. 3. PMA, D3, RA, 9-cis RA, and NaB elicit a dose-dependent increase in
ctsb mRNA levels. HL-60 cells were treated for 24 h with PMA, 9-cis RA, or
NaB and for 48 h with D3 or RA at the concentrations indicated. Northern
blotting was performed as described in Figure 1. For all treatments, the upper
box contains the ctsb mRNA bands, and the lower box contains the gapdh
mRNA bands.
TABLE 2. Differentiation of HL-60 Cellsa
Treatment 24 h 120 h
Control ,1 ,1
PMA ,1b 2 6 1b
D3 ,1 82 6 2
RA ,1 63 6 2
9-cis RA ,1 80 6 9
NaB ,1 83 6 3
aCells were treated for either 24 or 120 h as described in Materials and
Methods. The degree of differentiation is expressed as the percentage of cells
with formazan precipitates after staining with nitroblue tetrazolium. All
treatment conditions were examined four times, and the mean 6 standard error
is displayed.—bAfter PMA treatment, most cells were morphologically differen-
tiated (i.e., adherent and spread), although few formazan precipitates were seen.
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obtained similar results with actinomycin D concentrations as
low as 0.1 µg/mL (data not shown).
D3, RA, and 9-cis RA act by binding to VDR, RAR, and
RXR (vitamin D, retinoic acid, and retinoid X receptor)
members of the steroid/nuclear receptor family of transcription
factors [36]. These factors have been shown to form homo- and
heterodimers, with different binding affinities for various
promoter elements [37, 38]. Therefore, we examined the
combined effect of D3 and RA or D3 and 9-cis RA on
steady-state ctsb mRNA levels 48 h post-treatment. The effect
of D3 and retinoids was more pronounced than either agent
alone, and was additive (threefold stimulation with D3 and RA
or D3 and 9-cis RA vs. 1.3- to 2-fold stimulation for each agent
alone; Fig. 5). Therefore, the two classes of agents are likely to
act, in part, through different pathways.
With the exception of PMA, all agents tested here did not
alter ctsb RNA stability in actinomycin D assays. Therefore, our
next experiments tested the hypothesis that these agents
increase transcription of the ctsb gene. For these studies, we
sequenced a 1.8-kb fragment of genomic DNA containing the
promoter region of the human cathepsin B gene. As reported
previously, the promoter region contains no canonical TATA or
CAAT box immediately upstream of the transcription initiation
site [39] but contains several Sp1 sites. A search for consensus
VDR and RAR responsive elements revealed no matches.
There are numerous potential AP1 and AP2 sites and three
potential NF-kB sites.
For analysis of promoter activity, various fragments from the
ctsb promoter region were inserted into pGL3-Basic vector
(Promega) upstream of the luciferase reporter gene (Fig. 6A).
The first of the resulting plasmids, pSCB1, contains a 2.2-kb
ctsb fragment, including 1.8 kb of 58-flanking region, exon 1
(135 bp), and 339 bp of intron 1. Because we thought that the
splice donor site at the end of exon 1 might interfere with
expression of luciferase, pSCB2 was generated, where the last
79 bp of exon 1 and intron 1 were removed, leaving 1774 bp of
58-flanking region and 56 bp of exon 1. We also constructed
pSCB8, a deletion variant containing 49 bp of 58-flanking
region and 56 bp of exon 1. We transfected each of the above
plasmids into HL-60 cells via electroporation and measured
luciferase activity in protein extracts from cells treated for
12–16 h with PMA, D3, 9-cis RA, and NaB and paired untreated
cells from the same transfection. We observed a consistent
approximately sevenfold induction of luciferase expression by
Fig. 4. PMA increases the stability of ctsb mRNA in HL-60 cells. HL-60 cells were pretreated for 24 h with PMA, 9-cis RA, or NaB and for 48 h with D3 or RA at the
concentrations indicated in Figure 1. Cells were then treated with 5 µg/mL actinomycin D for the times indicated. (A) Northern blotting was performed as described in
Figure 1. (B) The relative amount of ctsb mRNA (% of levels at time zero) was plotted vs. time.
Fig. 5. D3 and retinoids exert additive effects on ctsb mRNA expression.
HL-60 cells were treated for 48 h with D3, RA, and 9-cis RA (each at 10-7 M)
singly or in combinations as indicated. Northern blotting was performed as
described in Figure 1.
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PMA for all three plasmids and a 6- to 14-fold induction
during treatment with NaB (Fig. 6B). D3 and 9-cis RA did not
significantly increase luciferase expression in this assay.
DISCUSSION
We demonstrate that various agents that induce HL-60 cells to
differentiate toward a monocytic or granulocytic phenotype
increase steady-state levels of ctsb mRNA. Several groups have
reported that this protease is expressed at elevated levels
during differentiation of certain cell types, perhaps contributing
to tissue remodeling that takes place at that time. In addition,
ctsb levels remain high in a subset of differentiated cells that
exhibit extensive lysosomal or secreted proteolytic activity.
Some of the best-documented examples are in the monocyte
cell lineage [7–12, 40]. Both PMA and 9-cis RA stimulate ctsb
mRNA expression in the monocytic THP-1 cell line [Troen et
al., unpublished data]. In the HL-60 model system, PMA-
induced differentiation toward the monocyte/macrophage path-
way is paralleled by an increase in ctsb protein and activity [20,
21]. Our study supports this earlier observation because PMA
exerts a pronounced effect on ctsb mRNA levels. Reddy et al.
[12] have shown that the cysteine proteases cathepsins B, L,
and S are synthesized and secreted at high levels by monocyte-
derived macrophages cultured on elastin-coated dishes and
play an active role in the dissolution of this extracellular matrix
protein. Cathepsin B is also expressed at high levels by
macrophages associated with the invasive edge of human colon
tumors [J. McKerrow, personal communication]. These observa-
tions are consistent with the fact that PMA, which induces an
adherent macrophage-like phenotype in HL-60 cells, elicits a
more pronounced increase in ctsb levels than do D3 and NaB,
which induce a nonadherent, monocyte-like phenotype [22].
The up-regulation of ctsb during differentiation of both
monocytic and granulocytic cells may reflect a general up-
regulation of lysosomal proteases to accommodate the in-
creased turnover of proteins in these cells compared with their
precursors. However, lithium chloride, which also can induce
granulocytic differentiation of HL-60 cells, failed to increase
ctsb mRNA levels (data not shown). Inducing agents promote
various degrees of differentiation toward a mature cell lineage.
Perhaps LiCl-treated HL-60 cells express a less differentiated
phenotype than do HL-60 cells treated with RA or 9-cis RA.
Like ctsb, the lysosomal aspartic protease cathepsin D is
induced in HL-60 cells treated with inducers of both monocytic
Fig. 6. Induction of luciferase activity after transient transfection of HL-60 cells with pSCB1, pSCB2, and pSCB8. (A) The pSCB1, pSCB2, and pSCB8 plasmids
were generated as described in Materials and Methods. The regions upstream of exon 1 are depicted by the open rectangles; the black rectangles represent part or all
of exon 1; and the stippled rectangle represents the first 339 bp of intron 1. (B) Plasmids were transfected into HL-60 cells via electroporation, and cells from a single
transfection were equally divided into two dishes. One dish of each set was treated with 10-8 M PMA, 10-7 M D3, 10-7 M 9-cis RA, or 5 3 10-4 M NaB, and the other
dish was treated with vehicle only. All cells were harvested after 12–16 h. For the experiments involving PMA, D3, and 9-cis RA treatments, equal amounts of protein
from each sample were used to measure luciferase activity. For the experiments involving NaB treatment, dual luciferase assays were performed on all the samples, as
described in Materials and Methods. Results are expressed as fold induction after treatment compared with the control dish from the same transfection, and shown as
mean induction 6 standard deviation. The number of transfections is shown beneath each column.
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and granulocytic differentiation [41]. In the latter case, the
regulation of cathepsin D mRNA expression by D3 and RA was
found to be at least partially independent of differentiation.
Because the effects of differentiating agents on ctsb transcript
levels occur within 12–24 h, i.e., before the development of
formazan granules in the nitroblue tetrazolium assay, these
effects are not secondary to terminal differentiation of HL-60
cells. Therefore, the ctsb gene may be targeted by cellular
factors that are activated or induced directly by the treatments
and/or the early stages of differentiation.
Several members of the steroid/nuclear receptor family of
transcription factors mediate the action of D3 and retinoids on
gene transcription. HL-60 cells express the retinoid receptors
RARa, RARb, and RXRa [42, 43] and the vitamin D receptor
[44, 45]. These receptors have been shown to form homo- and
hetero-dimers, with different binding affinities for various
promoter elements [37, 38]. RA binds primarily to RARa,
whereas 9-cis RA can bind to RARa, RARb, and RXRa [36].
In our study, the effects of D3 and retinoids on ctsb gene
expression are additive. Therefore, the two classes of agents
may act in part via distinct pathways, which converge on the
ctsb promoter. By sequence analysis, we have not detected
consensus responsive elements for vitamin D or retinoic acid
receptors in the promoter region of ctsb up to 1.8 kb upstream of
the transcription start point. Moreover, in transient transfection
assays D3 and 9-cis RA failed, within 16 h, to induce luciferase
expression under the control of the same promoter region.
Taken together with their delayed effect on ctsb expression, this
suggests that D3, RA, and 9-cis RA may act indirectly by
activating other factors that regulate ctsb gene transcription.
These factors may bind further upstream in the ctsb gene or
require a longer latency period than was allowed in transient
transfection assays. For the latter case, Sp1 may be a candidate
mediator of the effect of D3 because D3-induced differentiation
of HL-60 cells markedly increases Sp1 binding to DNA, and a
96-h treatment of HL-60 cells leads to the increased production
of the full-length Sp1 protein [46].
NaB may stimulate ctsb mRNA levels directly or indirectly
because NaB can enhance transcription via discrete elements
[47–49] or via histone hyperacetylation and opening of the
chromatin structure [50–52]. The results of our transient
transfection assays confirm that NaB stimulates transcription of
the ctsb gene. However, whether discrete butyrate response
elements are involved is still unknown because we were unable
to detect significant similarities with promoter regions where
such elements have been described. If NaB-responsive ele-
ments exist in the ctsb promoter, at least one of them must be
located within the 49 bp upstream of exon 1 and the 56 bp of
exon 1 present in pSCB8. Maiyar and Norman [53] have
demonstrated that NaB increases VDR activity in primary
chick kidney cells, which raises the possibility that D3 and NaB
can act in concert to regulate ctsb gene expression in HL-60
cells.
The mechanism of action of PMA is unique in that it appears
to involve both stabilization of ctsb mRNA (as shown by
actinomycin D decay assays) and transcriptional induction (as
demonstrated by transient transfection assays). This dual effect
may account for the marked increase in ctsb transcript levels
found in PMA-treated HL-60 cells compared with cells treated
with the other agents. Sequence analysis of the ctsb promoter
reveals the presence of numerous potential responsive elements
for PMA, including AP1, NF-kB, and Sp1 sites. It is interesting
that the pSCB8 plasmid responds to PMA treatment even
though no AP1 or NF-kB sites are present. Mutation of Sp1
sites in the CTSB promoter reveal that they play a significant
role in the basal transcription of the gene [S. Yan, I. Berquin, B.
Troen, and B. Sloane, unpublished results]. Because phorbol
ester treatment of K562 cells increases Sp1 expression and
DNA binding [54], we are currently assessing whether indi-
vidual Sp1 binding sites are required for induction of transcrip-
tion by PMA.
Actinomycin D has been reported to induce apoptosis at
concentrations similar to those generally used for RNA synthe-
sis inhibition [35]. Within 19 h of treatment with 0.1 µg/mL
actinomycin D, 60% of HL-60 cells undergo apoptosis, and
treatment with concentrations above 0.5 µg/mL induces 100%
apoptosis [35]. We observed the stabilization of ctsb mRNA
within 4 h of actinomycin D treatment at 0.1 µg/mL, i.e., at a
time before overt apoptosis. Although differentiating HL-60
cells do undergo some degree of apoptosis [55], we observed
stimulation of ctsb gene expression in response to PMA, D3, RA,
9-cis RA, and NaB treatments at doses and exposure times
where apoptosis was not apparent. Nonetheless, because ctsb is
elevated in several physiological and pathological processes
where apoptosis is involved, an intriguing possibility is that this
protease is regulated by factors related to the apoptotic
response.
In summary, inducers of monocytic and granulocytic differen-
tiation increase the levels of ctsb transcripts in HL-60 cells
before the achievement of a fully differentiated phenotype. This
indicates that these differentiation inducers may regulate ctsb
gene expression either directly or indirectly through a signal
transduction cascade triggered by the treatment. D3 and
retinoids exert additive effects, suggesting that these agents
stimulate ctsb gene expression through distinct pathways. The
monocyte/macrophage inducer PMA is the most potent of the
agents tested, and modulates ctsb expression in a dual fashion
at both transcriptional and posttranscriptional levels. NaB also
induces transcription of ctsb promoter fragments in transient
transfection assays. Future efforts will be directed at determin-
ing whether the effect of NaB is mediated via discrete
responsive elements. If such is the case, we will initiate a
search for potentially new transcription binding factors acting
on these elements.
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